Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk, a leading global healthcare company. Under the terms of the agreement, upon the closing of the transaction,…